The purpose of this acquisition is to perform a BPA call order for cryopreservation services for the DR. Kaplan gerardo from the FDA center for biologics evaluation and research (CBER)
Ended Awarded Last action
- Contract number
- 75F40124F19009
- Awardee
-
Charles River Laboratories, Inc. UEI NAPSK1UAMAE5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $12,009
Award facts
- Contract value 100% obligated
- $12,008.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, MA 01887, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,148 | |
| Original award | $14,156 |
About this award
The Food and Drug Administration's Center for Biologics Evaluation and Research awarded a BPA call order to Charles River Laboratories, Inc. for cryopreservation services valued at $12,008.50. The contract, executed on May 9, 2024, with an ultimate completion date of May 9, 2025, is structured as a firm fixed-price arrangement with no small business set-aside designation. Services will be performed at Charles River's facility in Wilmington, Massachusetts, in support of research activities related to Dr. Kaplan Gerardo.
This award represents a task order issued under Charles River's existing Blanket Purchase Agreement with the Defense Health Agency, reflecting the company's established role as a critical supplier of specialized biomedical research services to federal agencies. Charles River Laboratories, a global contract research organization headquartered in Wilmington, Massachusetts, maintains extensive federal relationships across the National Institutes of Health, Department of Defense, Centers for Disease Control and Prevention, and other agencies. The company's core competencies include cryopreservation and storage of genetic materials, laboratory animal procurement and maintenance, diagnostic testing, and specialized research support services that facilitate government-sponsored biomedical research initiatives.
Quick answers
Who was awarded contract 75F40124F19009?
75F40124F19009 was awarded to Charles River Laboratories, Inc. by Food and Drug Administration (Department of Health and Human Services) on May 9, 2024.
How much is contract 75F40124F19009 worth?
The government has obligated $12,009 on 75F40124F19009.
Is contract 75F40124F19009 an order under another contract?
Yes. 75F40124F19009 is a BPA call under 75F40121A00034, a blanket purchase agreement.
Was contract 75F40124F19009 competed?
The extent of competition for 75F40124F19009 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award